Antibody-mediated specific immunotherapy of allergy

Bibliography

• YAZDANBAKHSH M, KREMSNER PG, VAN REE R: Allergy, parasites and the hygiene hypothesis. Science (2002) 296:490–494.
   PubMed Web of Science ®Google Scholar
• BROIDE DH: Molecular and cellular mechanisms of allergic disease. I Allergy Clin.Immunol. (2001) 108:S65–S71.
   Google Scholar
• DUMONT FJ: Modulation of Thl and Th2 responses for immunotherapy. Expert Opin. Ther. Patents. (2002) 12(3):341–367.
   Web of Science ®Google Scholar
• •Update on the Th1rrh2 paradigm and its impact on the search for novel immunotherapeutic strategies.
   Google Scholar
• RANDOLPH DA, STEPHENS R, CARRUTHERS CJ, CHAPLIN DD: Cooperation between Thl and Th2 cells in a murine model of eosinophilic airway inflammation. j Clin. Invest. (1999) 104:1021–1029.
   PubMed Web of Science ®Google Scholar
• YSSEL H,GROUX H: Characterization ofT cell subpopulations involved in the pathogenesis of asthma and allergic diseases. Int. Arch. Allergy Immunol (2000) 121:10–18.
   PubMed Web of Science ®Google Scholar
• DUBUSKE LM: Mediator antagonists in the treatment of allergic disease. Allergy Asthma Proc. (2001) 22:261–275.
   PubMedGoogle Scholar
• BABU KS, ARSHAD SH, HOLGATE ST: Omalizumab, a novel antiIgE therapy in allergic disorders. Expert Opin. Biol. Ther. (2001) 1(6):1049–1058.
   PubMed Web of Science ®Google Scholar
• BARNES PJ: Cytokine modulators as novel therapies for asthma. Ann. Rev Pharmacol Toxicol. (2002) 42:81–98.
   PubMed Web of Science ®Google Scholar
• WOHLLEBEN G, ERB KJ: Atopic disorders: a vaccine around the corner? Trend s Immunol (2001) 22:618–626.
   PubMed Web of Science ®Google Scholar
• SPIEGELBERG HL, RAZ E: DNA-based approaches to the treatment of allergies. Cun: Opin. Mal Ther. (2002) 4:64–71.
   Google Scholar
• ROLLAND JM, DOUGLASS J, OHEHIR RE: Allergen immunotherapy: current and new therapeutic strategies. Expert Opin. Investig. Drugs (2000) 9(3):515–527.
   PubMed Web of Science ®Google Scholar
• ••Excellent review of the principle, utility andlimitations of allergen specific immunotherapy of allergy.
   Google Scholar
• ALT FR, KAY AB, LARCHE M: The potential of peptide immunotherapy in allergy and asthma. Cun: Allergy Asthma Rep. (2002) 2:151–158.
   Google Scholar
• VARGA EM, DURHAM SR: Allergen injection immunotherapy. Clin. Allergy Immunol. (2002) 16:533–549.
   Google Scholar
• ADKINSON NFJ: Immunotherapy for allergic rhinitis. N Engl. j Med. (1999) 341:522–524.
   Google Scholar
• VOLCHECK GW: Hymenoptera (apid andvespid) allergy: update in diagnosis and management. Chrr. Allergy Asthma Rep. (2002) 2:46–50.
   Google Scholar
• AALBERSE RC, SCHUURMAN J: IgG4 breaking the rules. Immunology (2002) 105:9–19.
   PubMed Web of Science ®Google Scholar
• WILSON DR, NOURI-ARIA KT, WALKER SM et al.: Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. I Allergy Clin Immunol. (2001) 107:971–976.
   PubMed Web of Science ®Google Scholar
• WALKER C, ZUANY-AMORIM C: New trends in immunotherapy to prevent atopic diseases. Trend s Pharmacol Sci. (2001) 22:84–90.
   Google Scholar
• ENG PA, REINHOLD M, GNEHM HE: Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy (2002) 57:306–312.
   PubMed Web of Science ®Google Scholar
• •Demonstrates that allergen immunotherapy exerts persistent beneficial effects in children with grass pollen allergy.
   Google Scholar
• JACQUEMIN MG, SAINT-REMY JM: Specific downregulation of antiallergen IgE and IgG antibodies in humans associated with injections of allergen-specific antibody complexes. Titer. Immortal. (1995) 2:41–52.
   Google Scholar
• SAINT-REMY JM: Modulation of antiallergen immune responses by allergen-antibody complexes. Adv. Exp. Med. Biol. (1996) 409:417–424.
   Google Scholar
• VAN OOSTERHOUT AJ, VAN ESCH B, HOFMAN G et al.: Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma. Am. J. Respir. Cell Mal Biol. (1998) 19:622–628.
   Web of Science ®Google Scholar
• YAMAUCHI N, ITO K, SUKO M, ISHII A, MIYAMOTO T: IgG2 antibodies block IgE antibody-induced asthma in guinea-pigs. Int. Arch. Allergy Appl. kimono]. (1986) 80:76–80.
   Google Scholar
• SCHWARZE J, CIESLEWICZ G, JOETHAM A et al.: Antigen-specific immunoglobulin-A prevents increased airway responsiveness and lung eosinophilia after airway challenge in sensitized mice. Am. J. Respir: Crit. Care Med. (1998) 158:519–525.
   PubMed Web of Science ®Google Scholar
• GERBER JS, MOSSER DM: Stimulatoryand inhibitory signals originating from the macrophage Fcy receptors. Microbes Infect. (2001) 3:131–139.
   PubMed Web of Science ®Google Scholar
• DESMEDT M, ROTTIERS P, DOOMS H, FIERS W, Grooten J: Macrophages induce cellular immunity by activating Thl cell responses and suppressing Th2 cell responses. J. Immortal (1998) 160:5300–5308.
   PubMed Web of Science ®Google Scholar
• TANG C, INMAN MD, VAN ROOIJEN N et al: Th Type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-y-dependent mechanism. J. kimono]. (2001) 166:1471–1481.
   Google Scholar
• BHATIA S, MUKHOPADHYAY S, JARMAN E et al.: Scavenger receptor-specific allergen delivery elicits IFN-y-dominated immunity and directs established TH2-dominated responses to a nonallergic phenotype. J. Allergy Chit. Immortal. (2002) 109:321–328.
   Google Scholar
• AKDIS CA, BLASER K: Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. Microbes Infect. (2001) 3:891–898.
   PubMed Web of Science ®Google Scholar
• BELLINGHAUSEN I, KNOP J, SALOGA J: The role of interleukin-10 in the regulation of allergic immune responses. Int. Arch. Allergy Immortal. (2001) 126:97–101.
   PubMedGoogle Scholar
• GORDON CJ, GRAFTON G, WOOD PM, LARCHE M, ARMITAGE RJ: Modelling the human immune response: can mice be trusted? Corr. Opin. Pharmacal (2001) 1:431–435.
   Google Scholar
• •A note of caution on extrapolating mouse predirtical data to the treatment of human immunopathology.
   Google Scholar
• POMES A,CHAPMAN MD: Can knowledge of the molecular structure of allergens improve immunotherapy? Corr. Opin. Allergy Clin. Immortal. (2001) 1:549–554.
   Google Scholar
• KUEHR J, BRAUBURGER J, ZIELEN S etal.: Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. j Allergy Chit. Immortal. (2002) 109:274–280.
   Google Scholar
• •Demonstrates that olamizumab cotreatment enhances the efficacy of allergen specific immunotherapy.
   Google Scholar
• VERNERSSON M, LEDIN A, JOHANSSON J, HELLMAN L: Generation of therapeutic antibody responses against IgE through vaccination. FASEB J. (2002): In press.
   Google Scholar